GTEX-1O97I
|
61-70
|
Male
|
GTEX-1O97I-1326 |
Liver
|
PAXgene |
2
|
2 pieces; 20% macrovesicular steatosis
|
Acceptable
|
|
GTEX-1O9I2
|
51-60
|
Male
|
GTEX-1O9I2-2326 |
Liver
|
PAXgene |
3
|
2 pieces, advanced autolysis. Established cirrhosis with diffuse macrovesicular steatosis
|
Acceptable
|
|
GTEX-1OJC4
|
51-60
|
Female
|
GTEX-1OJC4-1126 |
Liver
|
PAXgene |
1
|
2 pieces; congested
|
Acceptable
|
|
GTEX-1OZHM
|
41-50
|
Male
|
GTEX-1OZHM-1126 |
Liver
|
PAXgene |
2
|
2 pieces, pronounced centrilobular necrosis, 40% of parenchyma, moderate macrovesciluar steatosis
|
Acceptable
|
|
GTEX-1P4AB
|
51-60
|
Male
|
GTEX-1P4AB-1326 |
Liver
|
PAXgene |
2
|
2 pieces; extensive cirrhosis with >50% fibrous content
|
Unacceptable
|
|
GTEX-1PBJI
|
21-40
|
Female
|
GTEX-1PBJI-1026 |
Liver
|
PAXgene |
2
|
2 pieces, macrovesciular steatosis, moderate/marked, involved up to ~80% of parenchyma
|
Acceptable
|
|
GTEX-1PBJJ
|
21-40
|
Male
|
GTEX-1PBJJ-0626 |
Liver
|
PAXgene |
1
|
2 pieces; congestion
|
Acceptable
|
|
GTEX-1PIIG
|
21-40
|
Male
|
GTEX-1PIIG-1326 |
Liver
|
PAXgene |
1
|
2 pieces; mild to moderate autolysis and marked central fatty degeneration
|
Acceptable
|
|
GTEX-1POEN
|
21-40
|
Female
|
GTEX-1POEN-1526 |
Liver
|
PAXgene |
2
|
2 pieces, diffuse microvesicular steatosis, granulomas noted, ensquared
|
Acceptable
|
|
GTEX-1PPGY
|
61-70
|
Male
|
GTEX-1PPGY-2226 |
Liver
|
PAXgene |
1
|
2 pieces; marked congestion; mild steatosis
|
Acceptable
|
|
GTEX-1PPH6
|
61-70
|
Female
|
GTEX-1PPH6-1326 |
Liver
|
PAXgene |
1
|
2 pieces; mild macrovesicular steatosis no inflammation or fibrosis
|
Unacceptable
|
|
GTEX-1PPH7
|
41-50
|
Male
|
GTEX-1PPH7-0626 |
Liver
|
PAXgene |
1
|
2 pieces; <2% macrovesicular fat; no fibrosis or inflammation
|
Acceptable
|
|
GTEX-1PWST
|
61-70
|
Male
|
GTEX-1PWST-1326 |
Liver
|
PAXgene |
1
|
2 pieces, advanced cirrhosis/steatosis, chronic hepatitis
|
Unacceptable
|
|
GTEX-1QAET
|
51-60
|
Male
|
GTEX-1QAET-1026 |
Liver
|
PAXgene |
1
|
2 pieces; moderate increase in portal tract lymphocytes
|
Acceptable
|
|
GTEX-1QCLZ
|
61-70
|
Female
|
GTEX-1QCLZ-1226 |
Liver
|
PAXgene |
1
|
2 pieces; diffuse fatty degeneration (large and small fat droplets);one with bile ducts surrounded by dense fibrous tissue (outlined) and other covered by capsule at two sides (arrows)
|
Acceptable
|
|
GTEX-1QEPI
|
61-70
|
Female
|
GTEX-1QEPI-1326 |
Liver
|
PAXgene |
2
|
2 pieces; moderate to severe centrilobular macrovesicular steatosis
|
Acceptable
|
|
GTEX-1QMI2
|
61-70
|
Male
|
GTEX-1QMI2-1426 |
Liver
|
PAXgene |
1
|
2 pieces, moderate macrovesicular steatosis and bridging fibrosis approaching early cirrhosis
|
Acceptable
|
|
GTEX-1QP66
|
51-60
|
Male
|
GTEX-1QP66-0226 |
Liver
|
PAXgene |
1
|
2 pieces; capsule included (Arrows)
|
Acceptable
|
|
GTEX-1QP6S
|
41-50
|
Male
|
GTEX-1QP6S-1326 |
Liver
|
PAXgene |
1
|
2 pieces; marked congestion; mild to moderate fatty degeneration
|
Acceptable
|
|
GTEX-1QPFJ
|
21-40
|
Female
|
GTEX-1QPFJ-1126 |
Liver
|
PAXgene |
1
|
2 pieces; extensive panlobular macrovesicular steatosis; fibrous tissue on edge of 1 piece occupies 20% [outlined]
|
Acceptable
|
|
GTEX-1R46S
|
61-70
|
Female
|
GTEX-1R46S-1526 |
Liver
|
PAXgene |
1
|
2 pieces, mild macrovesicular steatosis ((<10%)
|
Acceptable
|
|
GTEX-1R9JW
|
21-40
|
Female
|
GTEX-1R9JW-0826 |
Liver
|
PAXgene |
1
|
2 pieces, diffuse macrovesicular steatosis, severe, >90% of parenchyma
|
Acceptable
|
|
GTEX-1R9K4
|
61-70
|
Male
|
GTEX-1R9K4-1626 |
Liver
|
PAXgene |
2
|
3 pieces; capsule included (arrows); advanced cirrhosis
|
Unacceptable
|
|
GTEX-1R9PM
|
21-40
|
Male
|
GTEX-1R9PM-0526 |
Liver
|
PAXgene |
1
|
2 pieces, macrovesicular steatosis, moderate, ~30-40% of parenchyma
|
Acceptable
|
|
GTEX-1R9PO
|
61-70
|
Female
|
GTEX-1R9PO-0826 |
Liver
|
PAXgene |
1
|
2 pieces; mild to moderate autolysis; marked congestion and fatty degeneration
|
Acceptable
|
|